People with Bleeding Disorders and HCV send letter to FDA Commissioner

HFA recognizes and supports efforts to further the development and availability of promising HCV therapies for the bleeding disorders community. Click here to read the recent letter to FDA Commissioner, Dr. Margaret Hamburg. Click here to read the MASAC Recommendations for Treatment of Chronic HCV Infection.